Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey.
- DOI
- 10.1007/s12672-026-05158-y
- Published
- 2026 May 8
- Container
- Discover oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12672-026-05158-y,
title = {Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey.},
author = {Bayram S and Koylu B and Mildanoglu MM and Demir B and Arvas H and Guven OD and Alemdar MS and Yerlikaya T and Selcukbiricik F and Bilici A and Uysal M and Kargi A and Tatli AM and Cakir MO and Ozdogan M},
year = {2026},
journal = {Discover oncology},
doi = {10.1007/s12672-026-05158-y},
url = {https://doi.org/10.1007/s12672-026-05158-y}
}RIS
TY - JOUR TI - Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey. AU - Bayram S AU - Koylu B AU - Mildanoglu MM AU - Demir B AU - Arvas H AU - Guven OD AU - Alemdar MS AU - Yerlikaya T AU - Selcukbiricik F AU - Bilici A AU - Uysal M AU - Kargi A AU - Tatli AM AU - Cakir MO AU - Ozdogan M PY - 2026 JO - Discover oncology DO - 10.1007/s12672-026-05158-y UR - https://doi.org/10.1007/s12672-026-05158-y ER -
APA
S, B., B, K., MM, M., B, D., H, A., OD, G., MS, A., T, Y., F, S., A, B., M, U., A, K., AM, T., MO, C., & M, O. (2026). Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey.. Discover oncology. https://doi.org/10.1007/s12672-026-05158-y
Source records
- pubmed · retrieved 2026-09-26T05:49:14.939Z